ZYN002: Phase II started

Zynerba began the double-blind, placebo-controlled, Australian Phase II STOP trial to evaluate 125 and 250 mg ZYN002 4.2% gel every 12 hours for 12 weeks in up to 300 patients with moderate to severe ...